Health
Nasal spray to fight COVID-19 could be manufactured in Australia – Manufacturers’ Monthly
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, backed by the $500 million Biomedical Translation Fund.
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, with backing from the federal government’s $500 million Biomedical Translation Fund.
Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.
The government, with Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment, that targets the primary…
-
Noosa News12 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General5 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
General16 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025